BillionaireNet
Mehta
Satish Mehta
Rank #2318
INDIAHealthcarePharmaceuticals

Satish Mehta

Net Worth
$1.611B
-0.45% (24h)
Satish Mehta, a prominent figure in the pharmaceutical industry, is the founder of Emcure Pharmaceuticals. Born in Pune, India, in 1950, he is currently 74 years old and has an estimated net worth of $1.7 billion. Mehta's career began in 1981 when he established Emcure as a contract manufacturer. Under his leadership, Emcure has grown into a multinational pharmaceutical enterprise, operating in over 70 countries. Mehta's journey is characterized by his ambition to democratize access to healthcare, making modern treatments available to even the most remote corners of India. He is a graduate of Pune University and the Indian Institute of Management, Ahmedabad.

The Full Dossier

Early Life

Satish Mehta was born in Pune, India, to a family involved in the pharmaceutical retail business. He pursued his education, earning a Bachelor of Science degree from Pune University, followed by a Master of Science degree from the same institution. Later, he obtained a PGDM (Post Graduate Diploma in Management) from the Indian Institute of Management, Ahmedabad.

Rise to Success

Mehta's entrepreneurial journey began in 1981 when he founded Emcure Pharmaceuticals. Initially, Emcure served as a contract manufacturer for multinational pharmaceutical companies. Over time, Mehta transitioned the company into selling its own branded generic formulations. His strategic vision and leadership have been instrumental in Emcure's expansion, making it a major player in the global pharmaceutical market.

Key Business Strategies

Key business strategies employed by Satish Mehta include a focus on research and development, global expansion, and strategic alliances. Emcure has invested heavily in R&D, establishing five major research centers and employing hundreds of scientists. Mehta prioritized stabilizing operations in India before expanding internationally, and he has formed strategic partnerships to bring world-class products to the Indian market at affordable prices.

Philanthropy

Satish Mehta has integrated social good with corporate growth. Emcure sponsors life-saving surgeries, supports education for underprivileged students, and has adopted villages to promote environmental sustainability. He also initiated the PRERNA program to empower women employees and the NEEM scheme to boost skill development. In addition, he serves as a chairman of Gennova, an Indian biotechnology company that is developing mRNA vaccine supported by DBT-BIRAC for COVID-19 in India.

Career Timeline

2024

Emcure Listed on Market

Emcure listed on the market at a 31% premium.

2016

Forbes India's Richest

Ranked as the 82nd richest Indian on the Forbes Rich List, with a net worth of $1.6 billion.

2005-06

Expanded into regulated markets

Entered regulated markets.

1981

Founded Emcure Pharmaceuticals

Started Emcure as a contract manufacturer for multinational companies.

Philanthropic Impact

HealthcareUnknown

Sponsorship of Surgeries

Emcure sponsors life-saving surgeries.

EducationUnknown

Education Support

Supports education for underprivileged students.

Environmental SustainabilityUnknown

Village Adoption

Adopts villages to promote awareness about environmental sustainability.

Wealth Trajectory